Chemical Properties:
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.Manufacturer Supply Rivaroxaban Related Intermediates: (S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 4-(4-Aminophenyl)morpholin-3-one CAS 438056-69-0 Rivaroxaban Intermediate CAS 446292-07-5 5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6 5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9 Rivaroxaban API CAS 366789-02-8| Item | Specifications |
| Appearance | White Powder |
| Purity / Analysis Method | ≥98.0% (HPLC) |
| Melting Point | 210.0℃～215.0℃ |
| Any Individual Impurity | ≤1.0% |
| Loss on Drying | ≤0.50% |
| Residue on Ignition | ≤0.10% |
| Test Standard | Enterprise Standard |
| Usage | Rivaroxaban (CAS: 366789-02-8) Intermediate |
Description:
Specifications:
Package & Storage:
| Chemical Name | 2-[(2R)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione |
| Synonyms | Rivaroxaban Intermediate |
| CAS Number | 446292-07-5 |
| CAT Number | RF-PI130 |
| Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
| Molecular Formula | C21H21N3O5 |
| Molecular Weight | 395.41 |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Stable Supply: Maintain reasonable stock
Professional Service: One stop purchasing service
Technical Support: Technology solution available
Custom Synthesis Service: Ranged from grams to kilos
Fast Delivery: If within stock, three days delivery guaranteed
High Quality: Established a complete quality assurance system
Application:
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 2-[(2R)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione (CAS: 446292-07-5) with high quality. It is an intermediate typically in the synthesis of Rivaroxaban (CAS: 366789-02-8). Rivaroxaban is a pure (S)-enantiomer. Rivaroxaban (BAY 59-7939) is an oral, direct factor Xa inhibitor in clinical development for the prevention and treatment of venous thromboembolism (VTE). Rivaroxaban is an antithrombotic drug and was developed in a collaboration between the German Bayer Pharmaceuticals and American Johnson company.Sufficient Capacity: Sufficient facilities and technicians
OEM Package: Custom package and label available
